Cargando…
Metabolic associated fatty liver disease is a risk factor for chronic kidney disease
BACKGROUND AND AIMS: To clarify the relationship between metabolic dysfunction‐associated fatty liver disease (MAFLD) and chronic kidney disease (CKD). METHODS: The participants were divided into four groups by the presence or absence of fatty liver disease (FLD) and metabolic dysfunction (MD). MAFL...
Autores principales: | Hashimoto, Yoshitaka, Hamaguchi, Masahide, Okamura, Takuro, Nakanishi, Naoko, Obora, Akihiro, Kojima, Takao, Fukui, Michiaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847128/ https://www.ncbi.nlm.nih.gov/pubmed/34561962 http://dx.doi.org/10.1111/jdi.13678 |
Ejemplares similares
-
Changes in metabolic complications in patients with alcoholic fatty liver disease monitored over two decades: NAGALA study
por: Hamaguchi, Masahide, et al.
Publicado: (2020) -
Obesity and metabolic abnormalities as risks of alcoholic fatty liver in men: NAGALA study
por: Yoshimura, Yuta, et al.
Publicado: (2021) -
Clinical characteristics and longitudinal changes of patients with non-alcoholic fatty liver disease in 2 decades: the NAGALA study
por: Okamura, Takuro, et al.
Publicado: (2021) -
Effect of alcohol consumption and the presence of fatty liver on the risk for incident type 2 diabetes: a population-based longitudinal study
por: Okamura, Takuro, et al.
Publicado: (2020) -
A weight regain of 1.5 kg or more and lack of exercise are associated with nonalcoholic fatty liver disease recurrence in men
por: Nakanishi, Naoko, et al.
Publicado: (2021)